Latest filing published 05 May 2023 for Orchestra BioMed Holdings, Inc..
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Connealy Pamela Yanchik: trading record in brief
Connealy Pamela Yanchik is a declared insider at 3 companies (finance chief); the most frequent names are Pyxis Oncology, Inc., Orchestra BioMed Holdings, Inc. and Immunovant, Inc. Between 19 March 2021 and 12 April 2023, the trades on record add up to 7 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The record was last updated on 5 May 2023 with an option exercise in Orchestra BioMed Holdings, Inc. The median gap between a trade and its publication by SEC (Form 4) is 4 days. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Connealy Pamela Yanchik
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 758 sharesCommon Stock, par value $0.0001 per share ("Common Stock")SEC:0001213900-23-037027:0
- 209,803 shares0Common StockSEC:0001209191-23-021413:0
- 3,488 sharesCommon Stock, par value $0.0001 per share ("Common Stock")SEC:0001213900-23-006193:0
- 43,493 shares0Common StockSEC:0001567619-23-000066:0
- 93,493 shares0Common StockSEC:0001567619-22-008615:0
- 247,524 shares0Common StockSEC:0001140361-22-012916:0
6 of 6 declarations
